Yield10 Bioscience
YTEN
Earnings for Yield10 Bioscience (YTEN)
Earnings in 2023 (TTM): -$14.46 M
According to Yield10 Bioscience's latest financial reports the company's current earnings (TTM) are -$14.46 M. In 2022 the company made an earning of -$13.41 M a decrease over its 2021 earnings that were of -$11 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Yield10 Bioscience from 2004 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$14.46 M | 7.79% |
| 2022 | -$13.41 M | 21.96% |
| 2021 | -$11 M | 8.33% |
| 2020 | -$10.15 M | -23.16% |
| 2019 | -$13.21 M | 43.85% |
| 2018 | -$9.19 M | -2.27% |
| 2017 | -$9.4 M | -8.65% |
| 2016 | -$10.29 M | -50.87% |
| 2015 | -$20.94 M | -21.78% |
| 2014 | -$26.77 M | -10.01% |
| 2013 | -$29.75 M | -919.48% |
| 2012 | $3.63 M | -109.35% |
| 2011 | -$38.82 M | -0.31% |
| 2010 | -$38.94 M | 0.54% |
| 2009 | -$38.73 M | -0.42% |
| 2008 | -$38.9 M | 15.01% |
| 2007 | -$33.82 M | 92.96% |
| 2006 | -$17.53 M | 149.46% |
| 2005 | -$7.03 M | 40.49% |
| 2004 | -$5.01 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.17 M | -85.05% | Bahamas |
 NRC Health
NRC | $40.82 M | -382.41% | 🇺🇸 USA |